Clinical Trial Update: Rituximab in Combination With Fludarabine and Cyclophosphamide in Patients With Chronic Lymphocytic Leukemia

View source ↗

Summary

This entry reports a completed clinical trial evaluating rituximab in combination with fludarabine and cyclophosphamide for chronic lymphocytic leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Cyclophosphamide (Cytoxan) (cyclophosphamide)
• Fludarabine (Fludara) (fludarabine)
• Rituximab (Rituxan) (rituximab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Lymphocytic Leukemia, Chronic, Chronic Lymphocytic Leukemia, Cancer | Status: COMPLETED